Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Boceprevir Therapy on HCV-specific T Cell Responses: Perspectives of Immune Monitoring and Immune Therapy

NCT01403181 is registered in ClinicalTrials.gov with Azienda Ospedaliero-Universitaria di Parma as lead sponsor.

NCT NCT01403181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01403181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Boceprevir Therapy on HCV-specific T Cell Responses: Perspectives of Immune Monitoring and Immune Therapy
Lead sponsor
Azienda Ospedaliero-Universitaria di Parma
Phase
Observational
Overall status
Completed
Start date
April 30, 2012
Completion date
Not reported
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c